Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Coagulation factor XI (Homo sapiens (Human)) | BDBM294112![]() (US10336741, Example 99 | US9585881, Example 99 | m...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.20 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Coagulation factor XI (Homo sapiens (Human)) | BDBM238259![]() (US10336741, Example 71 | US9394250, 71 | US9585881...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.20 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Coagulation factor XI (Homo sapiens (Human)) | BDBM238268![]() (US10336741, Example 98 | US9394250, 98 | US9585881...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.30 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Coagulation factor XI (Homo sapiens (Human)) | BDBM238252![]() (US10336741, Example 20 | US9394250, 20 | US9585881...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.20 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Coagulation factor XI (Homo sapiens (Human)) | BDBM406677![]() (US10336741, Example 96) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.20 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Coagulation factor XI (Homo sapiens (Human)) | BDBM238260![]() (US10336741, Example 73 | US9394250, 73 | US9585881...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.40 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Coagulation factor XI (Homo sapiens (Human)) | BDBM238265![]() (US10336741, Example 94 | US9394250, 94 | US9585881...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.40 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Coagulation factor XI (Homo sapiens (Human)) | BDBM238263![]() (US10336741, Example 88 | US9394250, 88 | US9585881...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.40 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Coagulation factor XI (Homo sapiens (Human)) | BDBM238261![]() (US10336741, Example 79 | US9394250, 79 | US9585881...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Coagulation factor XI (Homo sapiens (Human)) | BDBM238268![]() (US10336741, Example 98 | US9394250, 98 | US9585881...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.40 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Coagulation factor XI (Homo sapiens (Human)) | BDBM238269![]() (US10336741, Example 111 | US9394250, 111) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 8.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Coagulation factor XI (Homo sapiens (Human)) | BDBM294104![]() (US10336741, Example 86 | US9585881, Example 86 | m...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 9.90 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Coagulation factor XI (Homo sapiens (Human)) | BDBM238255![]() (US10336741, Example 43 | US9394250, 43 | US9585881...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Coagulation factor XI (Homo sapiens (Human)) | BDBM238253![]() (US10336741, Example 37 | US9394250, 37 | US9585881...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Coagulation factor XI (Homo sapiens (Human)) | BDBM238256![]() (US10336741, Example 55 | US9394250, 55 | US9585881...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 14 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Coagulation factor XI (Homo sapiens (Human)) | BDBM238251![]() (US10336741, Example 9 | US9394250, 9 | US9585881, ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 17 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Coagulation factor XI (Homo sapiens (Human)) | BDBM238264![]() (US10336741, Example 93 | US9394250, 93 | US9585881...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Coagulation factor XI (Homo sapiens (Human)) | BDBM238257![]() (US10336741, Example 57 | US9394250, 57 | US9585881...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 27 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Coagulation factor XI (Homo sapiens (Human)) | BDBM406666![]() (US10336741, Example 39) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 78 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombin and coagulation factor X (Homo sapiens (Human)) | BDBM238265![]() (US10336741, Example 94 | US9394250, 94 | US9585881...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >3.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombin and coagulation factor X (Homo sapiens (Human)) | BDBM238265![]() (US10336741, Example 94 | US9394250, 94 | US9585881...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >3.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombin and coagulation factor X (Homo sapiens (Human)) | BDBM238260![]() (US10336741, Example 73 | US9394250, 73 | US9585881...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.70E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombin and coagulation factor X (Homo sapiens (Human)) | BDBM238261![]() (US10336741, Example 79 | US9394250, 79 | US9585881...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombin and coagulation factor X (Homo sapiens (Human)) | BDBM238263![]() (US10336741, Example 88 | US9394250, 88 | US9585881...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.70E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombin and coagulation factor X (Homo sapiens (Human)) | BDBM294112![]() (US10336741, Example 99 | US9585881, Example 99 | m...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 8.40E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombin and coagulation factor X (Homo sapiens (Human)) | BDBM238259![]() (US10336741, Example 71 | US9394250, 71 | US9585881...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 9.40E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombin and coagulation factor X (Homo sapiens (Human)) | BDBM406677![]() (US10336741, Example 96) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombin and coagulation factor X (Homo sapiens (Human)) | BDBM238268![]() (US10336741, Example 98 | US9394250, 98 | US9585881...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombin and coagulation factor X (Homo sapiens (Human)) | BDBM238259![]() (US10336741, Example 71 | US9394250, 71 | US9585881...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombin and coagulation factor X (Homo sapiens (Human)) | BDBM238268![]() (US10336741, Example 98 | US9394250, 98 | US9585881...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombin and coagulation factor X (Homo sapiens (Human)) | BDBM238251![]() (US10336741, Example 9 | US9394250, 9 | US9585881, ...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombin and coagulation factor X (Homo sapiens (Human)) | BDBM238255![]() (US10336741, Example 43 | US9394250, 43 | US9585881...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombin and coagulation factor X (Homo sapiens (Human)) | BDBM238269![]() (US10336741, Example 111 | US9394250, 111) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombin and coagulation factor X (Homo sapiens (Human)) | BDBM238251![]() (US10336741, Example 9 | US9394250, 9 | US9585881, ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombin and coagulation factor X (Homo sapiens (Human)) | BDBM238260![]() (US10336741, Example 73 | US9394250, 73 | US9585881...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombin and coagulation factor X (Homo sapiens (Human)) | BDBM406677![]() (US10336741, Example 96) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombin and coagulation factor X (Homo sapiens (Human)) | BDBM238257![]() (US10336741, Example 57 | US9394250, 57 | US9585881...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombin and coagulation factor X (Homo sapiens (Human)) | BDBM238264![]() (US10336741, Example 93 | US9394250, 93 | US9585881...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombin and coagulation factor X (Homo sapiens (Human)) | BDBM238253![]() (US10336741, Example 37 | US9394250, 37 | US9585881...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombin and coagulation factor X (Homo sapiens (Human)) | BDBM238253![]() (US10336741, Example 37 | US9394250, 37 | US9585881...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombin and coagulation factor X (Homo sapiens (Human)) | BDBM238255![]() (US10336741, Example 43 | US9394250, 43 | US9585881...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombin and coagulation factor X (Homo sapiens (Human)) | BDBM294112![]() (US10336741, Example 99 | US9585881, Example 99 | m...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombin and coagulation factor X (Homo sapiens (Human)) | BDBM238252![]() (US10336741, Example 20 | US9394250, 20 | US9585881...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombin and coagulation factor X (Homo sapiens (Human)) | BDBM406666![]() (US10336741, Example 39) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombin and coagulation factor X (Homo sapiens (Human)) | BDBM238263![]() (US10336741, Example 88 | US9394250, 88 | US9585881...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombin and coagulation factor X (Homo sapiens (Human)) | BDBM294104![]() (US10336741, Example 86 | US9585881, Example 86 | m...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombin and coagulation factor X (Homo sapiens (Human)) | BDBM294104![]() (US10336741, Example 86 | US9585881, Example 86 | m...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombin and coagulation factor X (Homo sapiens (Human)) | BDBM238256![]() (US10336741, Example 55 | US9394250, 55 | US9585881...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombin and coagulation factor X (Homo sapiens (Human)) | BDBM238257![]() (US10336741, Example 57 | US9394250, 57 | US9585881...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombin and coagulation factor X (Homo sapiens (Human)) | BDBM238268![]() (US10336741, Example 98 | US9394250, 98 | US9585881...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombin and coagulation factor X (Homo sapiens (Human)) | BDBM238256![]() (US10336741, Example 55 | US9394250, 55 | US9585881...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombin and coagulation factor X (Homo sapiens (Human)) | BDBM238252![]() (US10336741, Example 20 | US9394250, 20 | US9585881...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombin and coagulation factor X (Homo sapiens (Human)) | BDBM238268![]() (US10336741, Example 98 | US9394250, 98 | US9585881...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombin and coagulation factor X (Homo sapiens (Human)) | BDBM238261![]() (US10336741, Example 79 | US9394250, 79 | US9585881...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombin and coagulation factor X (Homo sapiens (Human)) | BDBM406666![]() (US10336741, Example 39) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombin and coagulation factor X (Homo sapiens (Human)) | BDBM238264![]() (US10336741, Example 93 | US9394250, 93 | US9585881...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Ono Pharmaceutical Co., Ltd US Patent | Assay Description Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi... | US Patent US10336741 (2019) BindingDB Entry DOI: 10.7270/Q2CR5WQP | |||||||||||
More data for this Ligand-Target Pair |